Sansum Clinic
Decrease (-) Restore Default Increase (+) font size
PrintEmail
Share
Follow us on Facebook    Follow us on Twitter    View our YouTube Videos
 "Like" us on facebook

Channel Manager

Guillain-Barré Syndrome: Immunotherapy

Guillain-Barré Syndrome: Immunotherapy

Topic Overview

Guillain-Barré syndrome (GBS) is a rare nerve disorder that occurs when the body's own defenses (immune system) attack part of the nervous system. For this reason, you may be treated with immunotherapy, which is designed to alter or combat the abnormal immune response by removing the antibodies that are attacking your body.

Two types of immunotherapy may be used to treat GBS:

  • Plasma exchange , or plasmapheresis, is a procedure in which the liquid portion ( plasma ) of your blood is separated from the red and white blood cells and replaced with a saltwater (saline) and albumin ( protein ) solution. It removes antibodies and other potentially harmful factors from the bloodstream. Plasma exchange requires access to large veins, which may not be possible in some people, and it may be risky in older people or in some people who have heart disease.
  • Intravenous immune globulin (IVIG) is a medicine often used to boost the body's immune system and make it better able to fight disease. Immune globulins (also called gamma globulins) are proteins in human blood. These proteins are antibodies, which help the body's immune system recognize and destroy foreign substances, such as bacteria and viruses. Because immune globulin is made from donated blood fluids, it is sometimes in short supply and may not be available everywhere.

One of these treatments is often started immediately after you have been diagnosed with GBS that is getting worse. Early treatment may reduce your recovery time.

Plasma exchange and IVIG appear to be equally effective when given early in the course of the disease. They also have similar costs. The choice between one or the other treatment may depend on what is available and most practical.

Related Information

Credits

By Healthwise Staff
Primary Medical Reviewer Anne C. Poinier, MD - Internal Medicine
Specialist Medical Reviewer Colin Chalk, MD, CM, FRCPC - Neurology
Last Revised October 14, 2011

This information does not replace the advice of a doctor. Healthwise, Incorporated disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.

© 1995-2013 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.

 
© 2014 Sansum Clinic